Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer.

Xiu ShiJuan WangShou-Qian DaiLingyan QinJinhua ZhouYouguo Chen

Published in: OncoTargets and therapy (2020)

APOC1 acts as an oncogene in cervical cancers and knockdown of APOC1 inhibited cervical cancer cells growth in vitro and in vivo. There is a close relationship between the relative expression of APOC1 and clinical outcome in cervical cancer patients.

Keyphrases

poor prognosis
young adults
binding protein